Pravastatin was not better than usual care in reducing all-cause mortality or CHD events

Evans, Arthur T.; Lucas, Brian P.
July 2003
ACP Journal Club;Jul/Aug2003, Vol. 139 Issue 1, p10
Academic Journal
Provides information on a study which assessed whether pravastatin is better than usual care in reducing all-cause mortality and coronary heart diseases. Main outcome measures; Results; Details of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.


Related Articles

  • Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes. Cannon, Christopher P.; Braunwald, Eugene; McCabe, Carolyn H.; Rader, Daniel J.; Rouleau, Jean L.; Belder, Rene; Joyal, Steven V.; Hill, Karen A.; Pfeffer, Marc A.; Skene, Allan M. // New England Journal of Medicine;4/8/2004, Vol. 350 Issue 15, p1495 

    Background: Lipid-lowering therapy with statins reduces the risk of cardiovascular events, but the optimal level of low-density lipoprotein (LDL) cholesterol is unclear. Methods: We enrolled 4162 patients who had been hospitalized for an acute coronary syndrome within the preceding 10 days and...

  • Effects of Statin Therapy on Clinical Outcomes of Survivors of Acute Myocardial Infarction with Severe Systolic Heart Failure. Woo, Jong Shin; Hwang, Seung Joon; Kim, Hyun Soo; Kim, Jin Bae; Kim, Woo-Shik; Kim, Kwon Sam; Jeong, Myung Ho; Kim, Weon; null, null // PLoS ONE;12/11/2015, Vol. 10 Issue 12, p1 

    Objective: Large randomized trials have failed to show a beneficial effect of statin treatment in chronic HF. The investigators tried to evaluate the long-term effects of statin therapy in patients with new onset heart failure (HF) following acute myocardial infarction (AMI). Methods: Between...

  • Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from randomised trial of 20 536 people.  // BMJ: British Medical Journal (International Edition);12/2/2006, Vol. 333 Issue 7579, p1145 

    To evaluate the cost effectiveness of 40 mg simvastatin daily continued for life in people of different ages with differing risks of vascular disease. Design A model developed from a randomised trial was used to estimate lifetime risks of vascular events and costs of treatment and hospital...

  • Pravastatin: A Review of its Use in the Management of Hypercholesterolaemia or Mixed Dyslipidaemia. Duggan, Sean T. // Drugs;2012, Vol. 72 Issue 4, p565 

    Pitavastatin (Livazo®, Livalo®), an inhibitor of HMG-CoA reductase (statin), is indicated for the reduction of elevated total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) levels, in adult patients with primary hyper-cholesterolaemia and mixed dyslipidaemia, when...

  • Effectiveness of statins in chronic kidney disease. Sheng, X.; Murphy, M.J.; MacDonald, T.M.; Wei, L. // QJM: An International Journal of Medicine;Jul2012, Vol. 105 Issue 7, p641 

    Background: Previous studies show that statins reduce total cholesterol (TC) concentration by both 21% in primary prevention (PP) and secondary prevention (SP) in clinical trials and by ∼24% in the general population. There are few data about the efficacy of statins on TC concentration and...

  • Ni mucho, ni poco. Toledo, Rafael Bravo // AMF: Actualización en Medicina de Familia;2011, Vol. 7 Issue 1, p58 

    No abstract available.

  • Statins in the Treatment of Chronic Heart Failure: A Systematic Review. van der Harst, Pim; Voors, Adriaan A.; van Gilst, Wiek H.; Böhm, Michael; Veldhuisen, Dirk J. van // PLoS Medicine;Aug2006, Vol. 3 Issue 8, pe333 

    Background:The efficacy of statin therapy in patients with established chronic heart failure (CHF) is a subject of much debate.Methods and Findings:We conducted three systematic literature searches to assess the evidence supporting the prescription of statins in CHF. First, we investigated the...

  • Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice. Choudhry, Niteesh K.; Levin, Raisa; Winkelmayer, Wolfgang C. // Heart;Aug2007, Vol. 93 Issue 8, p945 

    Objective: To compare the effectiveness of statins of different treatment intensity used to treat elderly patients with acute coronary syndrome (ACS) in typical care settings. Design: Retrospective cohort study using linked hospital and pharmacy claims data. Setting: Statewide pharmacy benefits...

  • American Heart Association.  // BioWorld Today;11/17/2009, Vol. 20 Issue 222, p9 

    This article focuses on the interim data obtained by Aastrom Biosciences Inc. from the Phase II trial of its Cardiac Repair Cells (CRC). According to the study, patients treated with CRC showed improvement in their heart failure classification. The study also found that there was improved...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics